ARCHIVES

Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Trials Listed

April 28, 2006

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

March 7, 2014

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007